Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected.
Novo Surges As Ozempic Drives Fourth-Quarter Beat. But Supply Shortages Expected. · Investor's Business Daily

In This Article:

Novo Nordisk stock reversed a three-day downtrend Wednesday after the weight-loss drugs kingpin leaned on Ozempic for a fourth-quarter beat.